| The US Preventive Services Task Force Should Consider A Broader Evidence Base In Updating Its Diabetes Screening Guidelines. | |
| | |
MedLine Citation:
|
PMID: 22232092 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
Diabetes, especially type 2 diabetes, is on the rise throughout the United States. Several national health organizations and professional medical societies advocate screening people in high-risk groups for diabetes. However, the US Preventive Services Task Force recommends screening only adults with hypertension. We examined evidence supporting screening high-risk adults, including studies using intermediate outcomes and modeling studies. We found a broad range of evidence of practical relevance to diabetes screening that merits consideration in developing new screening guidelines. This evidence could inform recommendations to expand coverage to screening of other high-risk groups and could facilitate the prevention and early treatment of diabetes. We recommend that the US Preventive Services Task Force consider these expanded sources of evidence and revise its recommendations accordingly. |
| | |
Authors:
|
Christel Villarivera; Julie Wolcott; Anjali Jain; Yiduo Zhang; Clifford Goodman |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Health affairs (Project Hope) Volume: 31 ISSN: 1544-5208 ISO Abbreviation: Health Aff (Millwood) Publication Date: 2012 Jan |
Date Detail:
|
Created Date: 2012-01-10 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8303128 Medline TA: Health Aff (Millwood) Country: United States |
Other Details:
|
Languages: eng Pagination: 35-42 Citation Subset: IM |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Diabetes's 'Health Shock' To Schooling And Earnings: Increased Dropout Rates And Lower Wages And Emp...
Next Document: 'Personalized medicine' to identify genetic risks for type 2 diabetes and focus prevention: can it f...